Global Efficacy Testing Industry

Growing Competition in Consumer Markets, Plethora of Products With Myriad Claims Means Consumers Increasingly Want Proof of Efficacy. Efficacy Testing to Reach $866. 3 Billion. The global market for Efficacy Testing is projected to reach US$866.

New York, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Efficacy Testing Industry" - https://www.reportlinker.com/p05798446/?utm_source=GNW
3 million by the year 2027, trailing a post COVID-19 CAGR of 10.7% over the analysis period 2020 through 2027. Cosmetics, food and pharma companies are streamlining and revising the ingredients used in formulations continuously for optimized cost and efficacy. In the pharmaceuticals Industry, drug efficacy testing is important to validate safest and most efficient active compounds. Stringent FDA drug approval regulations are leading to increased preclinical drug efficacy testing. Pharma giants are increasingly outsourcing testing to drug efficacy testing service providers in a bed to cut costs. Using animal models is a popular way to test compounds for their effectiveness on specific diseases. The manufacturing of generic drugs as a key trend in the pharmaceutical industry also bodes well for growth in the market. With branded drugs taking around 7-10 years to reach commercialization, generic drugs are much more popular, as they take relatively less time to reach complete potential. Generic drugs are described as the bioequivalent versions of branded drugs in terms of safety, quality, stability, impact, strength, dosage form, and route of administration. Over the years, generic drugs have emerged as safe and effective alternatives to the brand name formulations. The generic variants often different from brand names in terms of certain characteristics such as color, flavoring and shape, although these factors do not have any impact on the safety and efficacy of the medicines compared to the original version. Generic drugs are made using the same active ingredients that are utilized in branded drugs. A key advantage for generic drug makers is that they do not need to invest time and money into drug R&D and marketing efforts, whereby the generic drugs are priced considerably low compared to branded counterparts. As generic drug making companies focus on the speed factor to ensure access to first-to-file status, efficacy testing becomes more important than before.

With growing number of products with beauty claims being launched in the market, the cosmetics industry is coming under intense scrutiny. Manufacturers are coming under increased pressure to support their product claims. Cosmetic efficacy testing is growing in value and popularity on par with the competitive need to innovate newer & better performing products. Educated and aware customers are also increasingly demanding evidentiary support for products’ claims. Also growing in popularity and importance are preservative efficacy test (PET) for cosmetics. Cosmetics manufacturers of today are facing the challenges associated with preservatives. While these companies must ensure that their products are free from harmful microorganisms and safe for use, they also need to contend with increasing consumer criticism against the use of such preservatives. For decades, parabens remained the first choice as preservatives for cosmetic products. Parabens are simple esters that offer an easy and effective way of imparting antimicrobial agents into moisturizers, haircare, and other makeup products. A study conducted in 1995 found that 99% of cosmetics contained parabens. In the early 2000s, there were shifts in the perceptions of safety of parabens due to studies showing that esters cause estrogenic effects. Since estrogenic chemicals are shown to play a key role in breast cancer, deeper research was taken up to find whether parabens are rapidly metabolized and excreted always, or they might linger in the body in some cases and be potentially harmful. By 2004, there were mounting concerns about the safety of esters when researchers showed the accumulation of intact parabens in human breast tumors. This is driving cosmetics manufacturers to look for alternative techniques of preservation. The past decade demonstrated the difficulty of finding preservatives with a broad and spectrum of antimicrobial effects with the robustness required to ensure safety while being sufficiently mild to avoid any negative interaction with other ingredients. Hurdle Technology, as the very name suggests, creates a series of hurdles, which might not be individually big enough to avert contamination, collectively, as back-to-back hurdles, they keep the microorganisms in control.

Health and wellness trend is ballooning into a major trend catalyzed by the COVID19 pandemic and the obsession with immunity building. The trend towards naturals has triggered robust growth in botanical research studies as increasing number of herbs and plant compounds are added to health products and dietary supplements. There is strong demand for bio-assays to test efficacy & biological activity of herbal ingredients in products. Of late, significant focus has been shed on regulating nutraceuticals and monitoring their efficacy claims. Convenience food has and will continue to remain a major trend in the food industry. With the packaged foods industry flooded with foods with various health claims, nutrition label analysis is growing in importance. Growing incidence of food fraud is throwing the spotlight on stricter regulations to ensure manufacturers take responsibility for food safety, traceability, recall and notification. A growing number of laboratories are beginning offer ingredient analysis services to analyze food products for their physical, chemical and microbiological properties.

Competitors identified in this market include, among others,

• American Type Culture Collection (ATCC)

• Becton, Dickinson and Company

• bioMerieux SA

• Charles River Laboratories International, Inc.

• Eurofins Scientific

• Merck KgaA

• North American Science Associates, Inc.

• Pacific Biolabs

• SGS SA

• Toxikon Corporation

• Wuxi Apptec Co., Ltd.

Read the full report: https://www.reportlinker.com/p05798446/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE I-1

II. EXECUTIVE SUMMARY II-1

1. MARKET OVERVIEW II-1
A Prelude to Efficacy Testing II-1
Global Efficacy Testing Market Poised for Steady Growth II-1
US Dominates, Asia-Pacific to Witness Rapid Growth II-1
Anti-microbial/Preservative Efficacy Testing to Register Rapid
Growth II-2
Disinfectant Efficacy Testing Dominates II-3
World Brands II-3

2. FOCUS ON SELECT PLAYERS II-4
Recent Market Activity II-4

3. MARKET TRENDS & DRIVERS II-5
Rising Importance of Preservative Efficacy Testing II-5
Challenge Organisms II-5
Testing Techniques II-5
Challenges II-6
Conclusion II-6
Preservation Technique for Paraben-Free Cosmetics II-6
Development of Alternative Techniques of Preservation II-7
Adoption of Hurdle Technology II-8
Preservative Systems in Liquid Dietary Supplements II-8
Preservative Efficacy Test (PET) for Cosmetics II-10
Efficacy Testing for Cosmetics II-11
Techniques Employed for Demonstrating Effectiveness of
Disinfectants II-11
Categorization of Test Types II-11
Surface Testing II-11
Additional Tests Mandated for the Pharmaceuticals Industry by
the USP II-12
Contact Time Defined II-12
Strong Rise in Pharmaceutical Sales to Drive Demand for
Efficacy Testing II-14
Exhibit 1: Global Prescription Drug Sales (In US$ Billion) for
the Years 2017, 2019, 2021, 2023 & 2025 II-15
Rapid Growth of Generic Drugs Drives Demand for Pharma Efficacy
Testing II-15
Exhibit 2: Global Generic Drugs Market Size (in $ Billion) for
the Years 2016, 2019, 2022 & 2025 II-16
Aging Population Propels the Demand for Ethicacy Testing in
End-use Applications II-17
Exhibit 3: Global Aging Population Statistics for the 65+ Age
Group in Million by Geographic Region for the Years 2019,
2025, 2035 and 2050 II-18
Increasing Healthcare Expenditure to Foster Growth II-18
Exhibit 4: World Healthcare Expenditure (In US$ Trillion) for
the Years 2017, 2019, 2021 & 2023 II-20
Persistent Increase in Pharmaceutical R&D Bodes Well for
Efficacy Testing II-20
Rising Incidence of Chronic Diseases Fuels Demand for Efficacy
Testing II-20
Exhibit 5: Global Cancer Incidence by Region: 2018 II-22
Exhibit 6: Global Cancer Incidence by Type: 2018 II-22
Exhibit 7: Fatalities by Heart Conditions: Estimated Percentage
Breakdown for Cardiovascular Disease, Ischemic Heart Disease,
Stroke, and Others II-23
Exhibit 8: Rising Diabetes Prevalence Presents Opportunity for
Cell Harvesting: Number of Adults (20-79) with Diabetes (in
Millions) by Region for 2017 and 2045 II-23
Consumables Segment Leads the Market II-24

4. GLOBAL MARKET PERSPECTIVE II-25
Table 1: World Current & Future Analysis for Efficacy Testing
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-25

Table 2: World Historic Review for Efficacy Testing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-26

Table 3: World 15-Year Perspective for Efficacy Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027 II-27

Table 4: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-28

Table 5: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 II-29

Table 6: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-30

Table 7: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-31

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 II-32

Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-33

Table 10: World Current & Future Analysis for Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-34

Table 11: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 II-35

Table 12: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027 II-36

Table 13: World Current & Future Analysis for Disinfectant
Efficacy Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 II-37

Table 14: World Historic Review for Disinfectant Efficacy
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 II-38

Table 15: World 15-Year Perspective for Disinfectant Efficacy
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027 II-39

Table 16: World Current & Future Analysis for Antimicrobial
Efficacy Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 II-40

Table 17: World Historic Review for Antimicrobial Efficacy
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 II-41

Table 18: World 15-Year Perspective for Antimicrobial Efficacy
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027 II-42

Table 19: World Current & Future Analysis for Pharmaceutical
Manufacturing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 II-43

Table 20: World Historic Review for Pharmaceutical
Manufacturing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 II-44

Table 21: World 15-Year Perspective for Pharmaceutical
Manufacturing by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027 II-45

Table 22: World Current & Future Analysis for Cosmetics &
Personal Care Products by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 II-46

Table 23: World Historic Review for Cosmetics & Personal Care
Products by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 II-47

Table 24: World 15-Year Perspective for Cosmetics & Personal
Care Products by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027 II-48

Table 25: World Current & Future Analysis for Medical Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-49

Table 26: World Historic Review for Medical Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 II-50

Table 27: World 15-Year Perspective for Medical Devices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027 II-51

III. MARKET ANALYSIS III-1

GEOGRAPHIC MARKET ANALYSIS III-1

UNITED STATES III-1
Table 28: USA Current & Future Analysis for Efficacy Testing by
Segment - Consumables, Instruments and Services - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-1

Table 29: USA Historic Review for Efficacy Testing by Segment -
Consumables, Instruments and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-2

Table 30: USA 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027 III-3

Table 31: USA Current & Future Analysis for Efficacy Testing by
Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 III-4

Table 32: USA Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 III-5

Table 33: USA 15-Year Perspective for Efficacy Testing by Type -
Percentage Breakdown of Value Sales for Disinfectant Efficacy
Testing and Antimicrobial Efficacy Testing for the Years 2012,
2020 & 2027 III-6

Table 34: USA Current & Future Analysis for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-7

Table 35: USA Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-8

Table 36: USA 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027 III-9

CANADA III-10
Table 37: Canada Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-10

Table 38: Canada Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-11

Table 39: Canada 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027 III-12

Table 40: Canada Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-13

Table 41: Canada Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 III-14

Table 42: Canada 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027 III-15

Table 43: Canada Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-16

Table 44: Canada Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-17

Table 45: Canada 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027 III-18

JAPAN III-19
Table 46: Japan Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-19

Table 47: Japan Historic Review for Efficacy Testing by Segment -
Consumables, Instruments and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-20

Table 48: Japan 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027 III-21

Table 49: Japan Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-22

Table 50: Japan Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 III-23

Table 51: Japan 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027 III-24

Table 52: Japan Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-25

Table 53: Japan Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-26

Table 54: Japan 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027 III-27

CHINA III-28
Table 55: China Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-28

Table 56: China Historic Review for Efficacy Testing by Segment -
Consumables, Instruments and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-29

Table 57: China 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027 III-30

Table 58: China Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-31

Table 59: China Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 III-32

Table 60: China 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027 III-33

Table 61: China Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-34

Table 62: China Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-35

Table 63: China 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027 III-36

EUROPE III-37
Table 64: Europe Current & Future Analysis for Efficacy Testing
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 III-37

Table 65: Europe Historic Review for Efficacy Testing by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 III-38

Table 66: Europe 15-Year Perspective for Efficacy Testing by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027 III-39

Table 67: Europe Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-40

Table 68: Europe Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-41

Table 69: Europe 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027 III-42

Table 70: Europe Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-43

Table 71: Europe Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 III-44

Table 72: Europe 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027 III-45

Table 73: Europe Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-46

Table 74: Europe Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-47

Table 75: Europe 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027 III-48

FRANCE III-49
Table 76: France Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-49

Table 77: France Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-50

Table 78: France 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027 III-51

Table 79: France Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-52

Table 80: France Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 III-53

Table 81: France 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027 III-54

Table 82: France Current & Future Analysis for Efficacy Testing
by Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-55

Table 83: France Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-56

Table 84: France 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027 III-57

GERMANY III-58
Table 85: Germany Current & Future Analysis for Efficacy
Testing by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-58

Table 86: Germany Historic Review for Efficacy Testing by
Segment - Consumables, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-59

Table 87: Germany 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027 III-60

Table 88: Germany Current & Future Analysis for Efficacy
Testing by Type - Disinfectant Efficacy Testing and
Antimicrobial Efficacy Testing - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 III-61

Table 89: Germany Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 III-62

Table 90: Germany 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant
Efficacy Testing and Antimicrobial Efficacy Testing for the
Years 2012, 2020 & 2027 III-63

Table 91: Germany Current & Future Analysis for Efficacy
Testing by Application - Pharmaceutical Manufacturing,
Cosmetics & Personal Care Products and Medical Devices -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-64

Table 92: Germany Historic Review for Efficacy Testing by
Application - Pharmaceutical Manufacturing, Cosmetics &
Personal Care Products and Medical Devices Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 III-65

Table 93: Germany 15-Year Perspective for Efficacy Testing by
Application - Percentage Breakdown of Value Sales for
Pharmaceutical Manufacturing, Cosmetics & Personal Care
Products and Medical Devices for the Years 2012, 2020 & 2027 III-66

ITALY III-67
Table 94: Italy Current & Future Analysis for Efficacy Testing
by Segment - Consumables, Instruments and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-67

Table 95: Italy Historic Review for Efficacy Testing by Segment -
Consumables, Instruments and Services Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 III-68

Table 96: Italy 15-Year Perspective for Efficacy Testing by
Segment - Percentage Breakdown of Value Sales for Consumables,
Instruments and Services for the Years 2012, 2020 & 2027 III-69

Table 97: Italy Current & Future Analysis for Efficacy Testing
by Type - Disinfectant Efficacy Testing and Antimicrobial
Efficacy Testing - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-70

Table 98: Italy Historic Review for Efficacy Testing by Type -
Disinfectant Efficacy Testing and Antimicrobial Efficacy
Testing Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 III-71

Table 99: Italy 15-Year Perspective for Efficacy Testing by
Type - Percentage Breakdown of Value Sales for Disinfectant

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05798446/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001